Preapproval Inspection and Submission to the FDA
Watch the Course Now
Watch the Course Now
About the Course
Preapproval inspections conducted by the U.S. Food and Drug Administration directly influence whether NDA, ANDA, and PMA applications progress toward approval or face delays, observations, or rejection. Manufacturing controls, testing practices, documentation accuracy, validation status, and facility conditions are closely reviewed to determine whether products are consistently produced in accordance with current Good Manufacturing Practices and applicable regulatory requirements. Weak inspection preparation frequently exposes gaps in quality systems, establishment records, and process controls that can affect approval timelines and post-submission actions.
This webinar addresses the operational and regulatory expectations associated with FDA preapproval inspections for pharmaceutical and medical device products. Particular attention is given to inspection focus areas under 21 CFR 210/211 and 21 CFR 820, including personnel practices, equipment readiness, establishment file reviews, process validation, and handling FDA inquiries. The course also examines inspection risk factors, material rejection concerns, pharmacovigilance considerations, and documentation practices supporting submission credibility.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


